Table 1. Clinical features of patients with COVID-19 in this study.
| Overall (n = 102) | |
|---|---|
| Age, year | 64.9±1.5 |
| Male, n (%) | 71 (70) |
| Onset to admission, day | 5.2±0.4 |
| Comorbidity, n (%) | 70 (69) |
| Diabetes mellitus, n (%) | 32 (31) |
| COPD, n (%) | 3 (3) |
| Hypertension, n (%) | 43 (42) |
| Heart disease, n (%) | 11 (11) |
| Chronic kidney disease, n (%) | 15 (15) |
| Treatments | |
| Oxygen support, n (%) | 71 (70) |
| Anti-viral agents, n (%) | 78 (76) |
| Inhaled steroid, n (%) | 63 (62) |
| Systemic steroid, n (%) | 36 (35) |
| Tocilizumab, n (%) | 3 (3) |
| Outcomes | |
| MV, n (%) | 30 (29) |
| ECMO use, n (%) | 5 (5) |
| In-hospital death, n (%) | 8 (8) |
| Severe ARDS, n (%) | 12 (12) |
Data are mean±SEM or number (%). COPD: chronic obstructive pulmonary disease, MV: mechanical ventilation. ECMO: extracorporeal membrane oxygenation, ARDS: acute respiratory distress syndrome.